Study Title and Description
Intravaginal clindamycin to reduce preterm birth in women with abnormal genital tract flora.
Key Questions Addressed
|4||Does treatment of bacterial vaginosis during pregnancy reduce preterm delivery and related morbidity and mortality? a) Does the effect of treatment vary by baseline risk (e.g., low- vs. high-risk) for preterm delivery? b) Does the effect of treatment vary by race/ethnicity? c) Does the effect of treatment vary by maternal age? d) Does the effect of treatment vary by gestational age? e) Does the effect of treatment vary by other risks for preterm delivery (e.g., coinfection with STIs, HIV status)?|
Primary Publication Information
|Title||Intravaginal clindamycin to reduce preterm birth in women with abnormal genital tract flora.|
|Author||Lamont RF., Duncan SL., Mandal D., Bassett P.|
|Country||Department of Obstetrics and Gynaecology, Northwick Park and St. Mark's Hospital, Watford Road, Harrow, Middlesex, London HA1 3UJ, United Kingdom. firstname.lastname@example.org|
Pubmed ID: 12636956
Secondary Publication Information
|Rescreening for abnormal vaginal flora in pregnancy and re-treating with clindamycin vaginal cream significantly increases cure and improvement rates.||Lamont RF., Taylor-Robinson D., Bassett P.||Department of Obstetrics and Gynaecology, University of Southern Denmark, University Hospital, Odense, Denmark. email@example.com||2012|
Extraction Form: Study Data for this published project can be accessed from the SRDR Published Projects page, under the link in the Study Notes section of this project
Results & Comparisons
No Results found.